Redox-modulation of regulated cell death: implications for synergistic anticancer therapies
Naunyn-Schmiedeberg's Archives of Pharmacology · 2026-07 · 399 (10) · 14807-14841
DOI: 10.1007/s00210-026-05320-x ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 08.05.2026. Verfasst von Pooja Singh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics, Faculty of Biomedical Sciences Technology and Research, Sri Ramachandra Institute of Higher Education and Research (Dee…. Hauptthemen laut MEDLINE: Neoplasms, Antineoplastic Agents, Regulated Cell Death. Die Arbeit nennt 372 Literaturangaben. Gefördert von: Department of Biotechnology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
Reactive oxygen and nitrogen species (RONS) constitute a unifying molecular axis across various cancer therapy modalities and are primary regulators of regulated cell death (RCD). Generally, cancer cells function under high oxidative stress to maintain proliferation, making them vulnerable to therapeutic approaches that push RONS levels above their survival threshold. The purpose of this review is to consolidate mechanistic evidence linking redox modulation to therapeutic efficacy. We analyzed current literature regarding standard and emerging anticancer modalities, including radiotherapy, proton therapy, FLASH therapy, chemotherapy, cold atmospheric plasma, photodynamic therapy, and engineered nanoplatforms. We specifically examined the molecular mechanisms by which these therapies induce mitochondrial ROS accumulation and trigger distinct cell death pathways. Our literature review indicates that these diverse modalities achieve tumor selectivity by increasing mitochondrial ROS beyond cytotoxic limits. When combined strategically, they further promote tumor-specific oxidative stress, maximizing therapeutic efficacy while minimizing damage to healthy tissues. We also highlight the critical biosafety considerations and regulatory frameworks necessary for the safe clinical translation of these RONS-based treatments. Redox-modulating strategies can address critical challenges, including chemoradiation resistance, metabolic rewiring, and the persistence of cancer stem cells. We propose that RONS-centered therapeutic design represents a viable strategy to improve the efficacy of contemporary cancer treatments by combining redox biology with cutting-edge therapeutic engineering. This graphical abstract depicts how various cancer treatment modalities cause RONS-mediated oxidative stress, hence activating different cell death pathways in cancer cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Human Genetics, Faculty of Biomedical Sciences Technology and Research, Sri Ramachandra Institute of Higher Education and Research (Deemed to Be University), Porur, Chennai, 600116, India.
- Department of Microbiology & Clinical Parasitology, College of Medicine, King Khalid University, 61421, Abha, Saudi Arabia.
- Department of Medical Oncology, Sri Ramachandra Institute of Higher Education and Research, Porur, Chennai, 610016, India.
- Department of Human Genetics, Faculty of Biomedical Sciences Technology and Research, Sri Ramachandra Institute of Higher Education and Research (Deemed to Be University), Porur, Chennai, 600116, India. rajesh.gandhiraj…
Förderung
- Department of Biotechnology, Ministry of Science and Technology, India
Zitieren
APA
Singh, P., Sridhar, S., Balasubramanian, D., Maigandan, D., Chandramoorthy, H. C., Ganesan, T., & Gandhirajan, R. K. (2026). Redox-modulation of regulated cell death: implications for synergistic anticancer therapies. Naunyn-Schmiedeberg's Archives of Pharmacology, 399(10), 14807-14841. https://doi.org/10.1007/s00210-026-05320-x
Vancouver
Singh P, Sridhar S, Balasubramanian D, Maigandan D, Chandramoorthy HC, Ganesan T, et al. Redox-modulation of regulated cell death: implications for synergistic anticancer therapies. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026;399(10):14807-14841. doi:10.1007/s00210-026-05320-x
BibTeX
@article{Singh2026,
author = {Singh, Pooja and Sridhar, Shreya and Balasubramanian, Dwarithaa and Maigandan, Devi and Chandramoorthy, Harish Chinnakonda and Ganesan, Trivadi and Gandhirajan, Rajesh Kumar},
title = {Redox-modulation of regulated cell death: implications for synergistic anticancer therapies},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
volume = {399},
number = {10},
pages = {14807--14841},
doi = {10.1007/s00210-026-05320-x}
}
EUVIMED